Primary Tumors

CHAPTER 41 Primary Tumors




INTRODUCTION


Primary tumors of the spine are uncommon, accounting for 5–10% of all primary skeletal tumors. At the Rizzoli Institute, 323 patients (adults and children) with primary spine neoplasms were seen over the past 50 years; 27% were malignant and 73% were benign.1 The most commonly encountered benign tumors of the mobile spine (the cervical, thoracic, and lumbar segments) include osteoblastomas, osteochondromas, giant cell tumors, hemangiomas, osteoid osteomas, and aneurysmal bone cysts. Common malignant primary tumors of the mobile spine include chordomas, chondrosarcomas, osteosarcomas, and Ewing’s sarcoma (Table 41.1). Less common malignant lesions of the mobile spine include solitary myeloma, solitary lymphoma, fibrosarcoma, and hemangioendothelioma.2 Chordomas and Ewing’s sarcomas are much more common in the sacrum. In fact, the incidences and clinical characteristics of many sacral tumors differ from those found in the mobile spine. Therefore, statistics and characteristics regarding sacral lesions are included in the discussion of these particular tumor types that are commonly found in the sacrum.


Table 41.1 Most Common Primary Tumors of the Mobile Spine



























Common Benign Primary Common Malignant Primary
Tumors of the Mobile Spine2,5 (%) Tumors of the Mobile Spine2 (%)
Osteoblastoma (20–23) Chordoma (33)
Osteochondroma (13–23) Chondrosarcoma (25)
Giant cell tumors (16–22) Osteosarcoma (19)
Hemangioma (10–20) Ewing’s (8)
Osteoid osteoma (7–21)  
Aneurysmal bone cyst (13)  

There is a strong correlation between patient age and likelihood of malignancy in primary tumors of the spine.3,4,5 In children, nearly 70% of primary tumors of the spine are benign,6 and 70% of primary spine tumors in adults (>21 years old) are malignant.7 As in many tumors, certain tumors of the spine have a predilection for certain age groups. In patients younger than 10 years, neuroblastoma, eosinophilic granuloma, and Ewing’s sarcoma dominate. Aneurysmal bone cysts, giant cell tumors, osteoid osteomas, osteoblastomas, and eosinophilic granulomas are the most frequent primary spine tumors found in adults less than 30 years of age. Patients between 30 and 50 years of age more often have chondrosarcoma, chordoma, lymphoma, and hemangioma as well as metastatic lesions. Those over 50 years of age mostly likely have metastatic disease, but may present with solitary myeloma or chondrosarcoma.8


The spine can be divided into anterior elements and posterior elements (Fig. 42.1). Anterior elements consist of the vertebral bodies, and the posterior elements include the remainder of the vertebra (pedicles, transverse processes, laminae, and the spinous process). Most malignant tumors, both primary and metastatic, occur in the anterior elements. Primary spine tumors located in the anterior elements have a 76% probability of being malignant. Those tumors located in the posterior elements are more likely benign (64%).6 Metastatic lesions of the spine are found in the anterior elements approximately 95% of the time. Common primary spine tumors involving the posterior elements are aneurysmal bone cysts, osteoblastomas, and osteoid osteomas. Primary spine tumors that have a predilection for the vertebral body include osteosarcomas, chordomas, solitary lymphomas, eosinophilic granulomas, giant cell tumors, and hemangiomas.8


An early diagnosis is critical in primary spinal tumors, for both local control and prevention of metastasis from malignant lesions. A high index of clinical suspicion and an awareness of symptoms related to the neoplastic conditions is therefore important to the practicing clinician. Significant improvements have aided diagnosis and treatment over the past several decades, and improved outcomes have resulted. Advances in imaging, such as magnetic resonance imaging (MRI) and computed tomography (CT), allow for detailed preoperative evaluation. This, along with improved instrumentation and surgical techniques, provides the means to achieve adequate surgical margins and reconstruction with less morbidity and mortality. Adjuvant therapy, such as radiation and chemotherapy, has also led to significant improvement in outcomes. Also, new minimally invasive techniques, such as radiofrequency ablation, selective arterial embolization, and vertebroplasty/kyphoplasty, have increased treatment options in some spine tumors.


The primary goals in treatment of primary spine lesions are to preserve/improve neurologic function, prevent/correct spinal instability, provide a cure/prevent metastasis, and alleviate pain. Because of the various treatment options, which involve many specialties, the treatment of a patient with a spine tumor requires a multidisciplinary approach, which often includes a pain specialist, medical oncologist, interventional radiologist, spine surgeon, physical medicine/rehabilitation specialist, social worker, and hospice care.



CLINICAL PRESENTATION


As mentioned previously, early diagnosis is critical in primary spinal tumors. Early detection can lead to optimal local control and prevention of distant spread. Therefore, a high index of clinical suspicion and an awareness of symptoms is vital. A careful history describing the characteristics and timeline of symptoms is important in diagnosis and may direct the work-up and treatment. A proper history includes a summary of prior treatment and provides a baseline to evaluate the course of the disease and the effect of therapy.





Pain


Back pain is the most common presenting symptom in both primary (84%)5 and secondary tumors (>90%)9,10 of the spine. Tumor pain is typically unrelenting, progressive, and often present during the night, although many types of pain can present. These include local, axial, radicular, and myelopathic pain, which are discussed in detail in the following chapter. Pain at night is particularly suggestive of tumors such as osteoid osteoma and sometimes more aggressive lesions. Tumor pain may be localized to a specific spinal segment or reproduced by pressure/percussion over the involved area. Tumor expansion may erode the cortical margins leading to pathologic fractures. Both pathologic fractures and tumor growth may involve the spinal canal and neural foramina, with compression of the cord and/or nerve roots resulting in neurologic deficits as well as pain. Ongoing destruction may also lead to development of spinal instability.


A history of persistent back pain should be taken seriously and usually warrants further investigation. Patients with a history of irradiation or Paget’s disease of the spine warrant added vigilance due to their risk of secondary osteosarcoma.11 In general, pain from tumors commonly mimics the pain produced by nontumorous disorders. Thus, it is necessary for the clinician to have a high index of suspicion when dealing with back pain, even if the patient does not present with the characteristic types of pain associated with spinal tumors.





PHYSICAL EXAM


A complete examination of the spine and neurologic function should be performed on any patient with a suspected tumor of the spine. Also, a search for signs of a primary malignancy responsible for metastatic lesions to spine is necessary if metastatic disease is in the differential. Careful examination of the neck, breasts, lungs, abdomen, and prostate as well as a search for lymphadenopathy can often reveal a potential source of metastatic spinal tumors.



Musculoskeletal inspection of the spine


The patient should be inspected for any obvious deformities of the spine and abnormal posturing. A bony prominence, kyphotic deformity, or acute angular scoliosis can be observed after vertebral collapse.13 Scoliosis is often associated with osteoid osteoma and osteoblastoma located on the concave side of the apical portion of the deformity. Spine tumors are rarely palpable due to the amount of tissue and muscle layers superficial to the spine. However, the spinous processes of the spine should be palpated, while paying special attention to any tenderness, masses, vertebral defects, and spastic paraspinal musculature. Range of motion testing in flexion, extension, rotation, and lateral bending should be carefully performed.




WORK-UP



Laboratory studies


The laboratory work-up in a patient with a suspected tumor of the spine can be involved. A complete blood count (CBC) with a differential is important when working up any suspected malignancy. Elevated erythrocyte sedimentation rates (ESR) and C-reactive protein (CRP) levels signal that an inflammatory process is involved, but cannot consistently differentiate an infectious process from a malignancy. Lactate dehydrogenase (LDH) levels can be elevated in sarcomas, and LDH isoenzymes 2 and 3 can suggest a diagnosis of lymphoma.15 To evaluate for liver cancer, alpha fetoprotein (AFP) levels are often obtained in patients with hepatitis C or those who are heavy drinkers. Carcinoembryonic antigen (CEA) is a marker of adenocarcinomas such as colonic, rectal, pancreatic, gastric, and breast.16 Prostate specific antigen (PSA) levels can help diagnose prostate cancer. A thyroid panel can help eliminate the suspicion of a rare thyroid primary, and parathyroid hormone (PTH) can be ordered to look for hyperparathyroidism. An elevated PTH level may lead to diagnosis of a brown tumor of the spine. The diagnosis of myeloma can be confirmed by the identification of monoclonal proteins in the serum or urine via serum protein electrophoresis (SPEP) or urine protein electrophoresis (UPEP);17 however, monoclonal proteins are more often absent or undetectable in solitary myeloma compared to multiply myeloma.18 A chemistry panel can be used to assess kidney function and allows calcium and phosphate levels to be followed to detect and avoid the development of malignant hypercalcemia. An elevated alkaline phosphatase level can also suggest a neoplastic bone disease.



Imaging techniques






Myelography (conventional and CT-myelography)


To perform a myelogram, iodinated contrast material is instilled into the dural sac in order to detect external compression of the sac or space-occupying lesions within the spinal cord. Therefore, it is an invasive procedure with inherent risks. Before MRI, conventional myelography was the gold standard for detection of cord compression and intrinsic cord lesions, but it has been largely replaced by MR scanning, and by CT-myelography when MRI is contraindicated. Myelography may fail to reveal secondary sites of epidural spinal cord compression and has been shown to be less sensitive in diagnosing spinal tumors than MRI.20 CT-myelography, like conventional myelography, involves the instillation of contrast into the dural sac, but the amount of contrast used is much less due to the enhanced ability of CT to depict subtle contrast differences. By employing various window settings for the images, details of the paraspinal structures, bone, and dural sac contents are well demonstrated. Both conventional and CT-myelography may be used when metallic fixation devices have been placed in and around the spine and MRI is unable to provide adequate images. This, however, is becoming less frequent with the increased use of titanium spinal hardware.



Magnetic resonance imaging


MRI detects spinal and paraspinal pathology better than any other imaging technique. It reliably depicts changes in the water content of structures, and thus most pathology, before changes in gross architecture occur. Pathology is detected by employing imaging sequences that emphasize various components of tissues such as fat, fluid, and vascularity. MR images can be obtained in any plane without changing the patient’s position. It is the only noninvasive technique able to visualize pathology within the spinal cord, and clearly depicts the degree of cord compression, as well as the process causing the compression. MR imaging defines lesions in the vertebrae as well as disc pathology and is the best method to diagnose discitis and paraspinal infections. MRI is also more reliable than other techniques in separating benign compression fractures from pathologic fractures of the vertebral bodies. This distinction is made by analyzing signal intensity changes in the bone and paraspinal space as well as by evaluating the shape of the vertebrae and integrity of the cortical margins.


The intrinsic contrast created by the tumor itself relative to the intensities of the normal vertebrae are usually sufficient to detect a primary or metastatic lesion in the spine. Contrast may be helpful to detect adjacent soft tissue invasion. It is also useful to know if a lesion enhances, as small foci of recurrent tumor may be more easily detected if they enhance, especially in a background of extensive postoperative change. Another purpose of contrast is in the detection of internal necrosis, a marker for the response of a tumor to chemotherapy. If a tumor enhances fairly solidly, with a response to chemotherapy, nonenhancing foci of necrosis appear within the lesion.


Limitations of MRI include the relatively long time to acquire a complete imaging sequence (at least 1 hour to study the entire spine in detail), degradation of the images by patient motion and by implanted metal such as fixation devices, the need for the patient to be able to lie flat and supine for the study, and contraindications such as pacemakers, various other implanted electronic devices, brain aneurysm clips of uncertain composition, and claustrophobia.


Magnetic resonance angiography (MRA) can help in defining the vascularity of the lesions and preoperative evaluation and may also play a role in defining the response to adjuvant therapy.



Positron emission tomography


The most common radiotracer used in clinical positron emission tomography (PET) imaging is fluorine-18-fluoro-2-D-deoxyglucose (18F-FDG), which accumulates in areas of high glycolysis and membrane transport of glucose, both known to be increased in malignant tissue. Unlike the agent used in bone scanning, 18F-FDG may detect bone marrow-occupying lesions before cortical involvement occurs, thus detecting bone metastases before they can be found on bone scans. Sclerotic metastases, however, as found in some breast and prostate cancers, are less likely to be detected by PET as these lesions have lower glycolytic rates and are less cellular than lytic metastases.21 18F-FDG is not specific for tumors and may accumulate at sites of infection but is less likely to be detected at sites of degenerative change than technetium 99m, the agent used in bone scans. Therefore, it is somewhat more specific for tumors. PET also demonstrates metastases in soft tissue throughout the body, resulting in additional diagnostic value.


In addition to detecting spine tumors, PET may also be useful in distinguishing malignant lesions from benign. One study of 29 patients with cancer and spine abnormalities showed that two nuclear medicine physicians were in agreement in calling abnormalities benign, equivocal, or metastasis in 90%.22 In addition, 100% of abnormalities interpreted as benign or malignant were correctly identified. The only discrepancies were in three abnormalities that were interpreted as equivocal and which turned out to be metastatic. CT and/or MRI were important in arriving at the final diagnosis in equivocal cases.


The ability of PET to evaluate the response of bone tumors to chemotherapy has also been studied. In one study of patients who underwent preoperative chemotherapy for osteosarcoma, changes in tumor 18F-FDG uptake were correlated with percentage tumor necrosis on histopathology. Tumor necrosis was accurately predicted on PET scan in 15 out of 16 patients by visual assessment and in 14 out of 15 patients by final tumor to background ratio (TBR).23



Biopsy


When a lesion is identified with the appropriate imaging, it is usually necessary to establish a histologic diagnosis for purposes of treatment, especially if treatment involves radiation, chemotherapy, or a surgical procedure. This helps to avoid misdiagnosis and erroneous treatment.



Types of biopsy


There are two types of biopsy commonly used for biopsy of spinal lesions: percutaneous, guided and open, surgical biopsy. Both fluoroscopic-guided and CT-guided percutaneous biopsies can be utilized, and both are effective. The tip accuracy of CT makes it superior when dealing with small, deep-seated lesions especially in the cervical and thoracic regions.24 CT better allows selection of the optimal location to sample tissue. For lesions visible via fluoroscopic monitoring, fluoroscopic-guided biopsy offers real-time positioning of the needle. Open biopsy maximizes tissue retrieval and providing the highest diagnostic success rate; however, it is typically reserved for failed percutaneous biopsies due to the increased morbidity of the open procedure and greater risk of wound contamination with tumor. Regardless of which method is used, the goal is to obtain an adequate amount of tissue while minimizing complications.





Complications of biopsy


Biopsies of potentially tumorous lesions should be well planned. It is well known that inadequate or inappropriate biopsies adversely affect outcome. Complications arising in these unsound biopsies include disability due to more complex resection, loss of function, local recurrence, and death.28 The surgeon that will be performing the definitive surgical procedure, if further surgery becomes necessary, should always perform the open biopsy. This ensures that the subsequent surgery can be performed using the optimal incision and approach, while excising the biopsy incision and tract. This can also help eliminate unnecessary and improperly performed open biopsies.


Complications of percutaneous needle biopsy include bleeding, infection, neurologic compromise, fracture, biopsy tract contamination, and death, although serious complications are rare. Due to the risk of tumor contamination of the biopsy tract,29 the needle tract should be excised if a subsequent surgery is indicated, although this is somewhat controversial. Whenever possible, guided biopsies should be done at the same institution where definitive surgical treatment will occur. Typically, pathologists at the larger referral centers will be more experienced with uncommon primary and secondary malignant tissues obtained from the spine and will typically review specimens despite previous histologic diagnosis from outside institutions. Also, a team approach between the interventional radiologist and the treating surgeon is more likely to produce a favorable result.




BENIGN TUMORS OF THE SPINE



Eosinophilic granuloma


Also known as Langerhans cell histiocytosis (LCH), eosinophilic granuloma is a benign and self-limiting process that can lead to focal destruction of bone. It is most prevalent in children, with half of patients under the age of 10 years. The etiology is unknown and the lesion is comprised of lipid-containing histiocytes from the reticuloendothelial system and eosinophils. Lesions are most common in the skull although virtually any bone may be affected, with vertebral involvement occurring in approximately 10–15% of cases. The most common appearance is a well-circumscribed, punched-out lesion with no periosteal reaction. Less common is the moth-eaten pattern with periosteal reaction. Both are demonstrated in Figure 41.2. Vertebral destruction with complete collapse of the vertebral body can occur and is classically referred to as ‘vertebra plana.’ Multiple vertebrae may occasionally be involved. Collapse can produce pain and spasm of the paraspinal muscles. Deformities in the form of gibbus or kyphus may develop in some cases. Diagnosis is confirmed by needle or open biopsy.


Stay updated, free articles. Join our Telegram channel

Sep 8, 2016 | Posted by in PHYSICAL MEDICINE & REHABILITATION | Comments Off on Primary Tumors

Full access? Get Clinical Tree

Get Clinical Tree app for offline access